Moderna Says Covid Vaccine "Highly Effective" In Adolescents

"We will submit these results to the US FDA and regulators globally in early June and request authorization," Moderna said in a statement.

US biotech firm Moderna said Tuesday that trials had shown its Covid-19 vaccine is "highly effective" in adolescents aged 12-17 and the company would seek regulators' approval in June. "We are encouraged that mRNA-1273 was highly effective at preventing Covid-19 in adolescents," CEO Stephane Bancel said in a statement. "We will submit these results to the US FDA and regulators globally in early June and request authorization."